Prenetics Global Limited Class A Ordinary Share (PRE)

$5.66 -0.27 (-4.63%)
Market Cap 54.20M
Revenue (ttm) 21.74M
Net Income (ttm) -62.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -288.50%
Debt to Equity Ratio 0.00
Volume 5,500
Avg Vol 9,976
Day's Range N/A - N/A
Shares Out 9.14M
Stochastic %K 56%
Beta -0.30
Analysts Strong Sell
Price Target $9.00

Latest News on PRE

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Jan 15, 2025, 8:30 AM EST - 2 days ago

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Dec 5, 2024, 8:30 AM EST - 6 weeks ago

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Prenetics Announces Participation in December Investor Conferences

Dec 4, 2024, 4:05 PM EST - 6 weeks ago

Prenetics Announces Participation in December Investor Conferences

Prenetics Announces Third Quarter 2024 Financial Results

Nov 27, 2024, 8:30 AM EST - 7 weeks ago

Prenetics Announces Third Quarter 2024 Financial Results

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:57 AM EST - 2 months ago

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:00 AM EST - 2 months ago

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Oct 30, 2024, 4:15 PM EDT - 2 months ago

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Aug 19, 2024, 8:30 AM EDT - 5 months ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Jul 11, 2024, 8:30 AM EDT - 6 months ago

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Jul 1, 2024, 8:30 AM EDT - 7 months ago

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Prenetics Announces First Quarter 2024 Financial Results

Jun 18, 2024, 8:30 AM EDT - 7 months ago

Prenetics Announces First Quarter 2024 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Apr 1, 2024, 7:30 AM EDT - 10 months ago

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Feb 9, 2024, 9:25 AM EST - 1 year ago

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Prenetics Announces Third Quarter 2023 Financial Results

Nov 20, 2023, 6:00 AM EST - 1 year ago

Prenetics Announces Third Quarter 2023 Financial Results

Prenetics Global Limited Announces Reverse Stock Split

Nov 1, 2023, 6:00 AM EDT - 1 year ago

Prenetics Global Limited Announces Reverse Stock Split

Prenetics Announces Second Quarter 2023 Financial Results

Sep 15, 2023, 6:58 AM EDT - 1 year ago

Prenetics Announces Second Quarter 2023 Financial Results

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Jun 26, 2023, 2:18 AM EDT - 1 year ago

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Jun 25, 2023, 8:45 PM EDT - 1 year ago

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Prenetics Announces First Quarter 2023 Financial Results

Jun 5, 2023, 7:00 AM EDT - 1 year ago

Prenetics Announces First Quarter 2023 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 14, 2023, 8:49 AM EDT - 2 years ago

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Mar 2, 2023, 7:00 AM EST - 2 years ago

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Feb 2, 2023, 4:01 PM EST - 2 years ago

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Jan 19, 2023, 5:00 AM EST - 2 years ago

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Prenetics Global's stock rallies 82%

Jan 10, 2023, 8:30 AM EST - 2 years ago

Prenetics Global's stock rallies 82%

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Jan 10, 2023, 6:00 AM EST - 2 years ago

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Dec 16, 2022, 6:27 AM EST - 2 years ago

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Nov 30, 2022, 9:15 AM EST - 2 years ago

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Nov 10, 2022, 8:00 AM EST - 2 years ago

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Sep 9, 2022, 9:02 AM EDT - 2 years ago

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

Jun 6, 2022, 6:45 AM EDT - 2 years ago

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

Prenetics Rings the Opening Bell and Debuts on Nasdaq

May 18, 2022, 6:30 PM EDT - 2 years ago

Prenetics Rings the Opening Bell and Debuts on Nasdaq